Letter to the Editor: The Cannabinoid Consumed Is Not Necessarily the One Expected: Recent Experience with Hexahydrocannabinol
Publication: Cannabis and Cannabinoid Research
Volume 9, Issue Number 5
Get full access to this article
View all available purchase options and get full access to this article.
References
1. European Monitoring Centre for Drugs and Drug Addiction. Hexahydrocannabinol (HHC) and related substances: technical report. LU: Publications Office; 2023. Available from: https://data.europa.eu/doi/10.2810/852912 [Last accessed: July 6, 2023].
2. Golombek P, Müller M, Barthlott I, et al. Conversion of cannabidiol (CBD) into psychotropic cannabinoids including tetrahydrocannabinol (THC): A controversy in the scientific literature. Toxics 2020;8(2):41.
3. Ujváry I. Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review. Drug Test Anal 2023 [Online ahead of print];
4. Arbouche N, Gheddar L, Guyon J, et al. Pediatric cannabis intoxication in France and Belgium: A 3-year retrospective study. Toxicol Anal Clin 2023;4481(1):1.
5. Spindle TR, Cone EJ, Kuntz D, et al. Urinary pharmacokinetic profile of cannabinoids following administration of vaporized and oral cannabidiol and vaporized CBD-dominant cannabis. J Anal Toxicol 2020;44(2):109–125.
Information & Authors
Information
Published In
Cannabis and Cannabinoid Research
Volume 9 • Issue Number 5 • October 2024
Pages: e1459 - e1461
PubMed: 37585622
Copyright
Copyright 2023, Mary Ann Liebert, Inc., publishers.
History
Published in print: October 2024
Published online: 16 August 2023
Topics
Authors
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.